Literature DB >> 18804505

Comparison of the immunomodulatory effects of L. donovani and L. major excreted-secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cells.

Matthieu Revest1, Ludovic Donaghy, Florian Cabillic, Claude Guiguen, Jean-Pierre Gangneux.   

Abstract

In an experimental model of human monocyte-derived dendritic cells (DCs), the immunophenotype of mature DCs infected with Leishmania donovani and Leishmania major showed a weak decrease in the cell surface expression of CD40, CD86, HLA-DR and DC-SIGN compared with uninfected control DCs. This immunomodulatory effect was more pronounced after stimulation with excreted-secreted antigens (ESA) of both species but absent after stimulation with particulate and soluble extracts. Infection with viable promastigotes, as well as stimulation with ESA from L. donovani and L. major, decreased IL-10 and IL-12p70 secretion. To our knowledge, this is the first direct demonstration that ESA from Leishmania promastigotes can stimulate DCs in the same manner as viable promastigotes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804505     DOI: 10.1016/j.vaccine.2008.09.005

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Modulation of dendritic cell responses by parasites: a common strategy to survive.

Authors:  César A Terrazas; Luis I Terrazas; Lorena Gómez-García
Journal:  J Biomed Biotechnol       Date:  2010-02-24

Review 2.  Dendritic cells and parasites: from recognition and activation to immune response instruction.

Authors:  Claudia Cristina Motran; Laura Fernanda Ambrosio; Ximena Volpini; Daiana Pamela Celias; Laura Cervi
Journal:  Semin Immunopathol       Date:  2016-09-01       Impact factor: 9.623

Review 3.  Trichinella spiralis: shaping the immune response.

Authors:  Natasa Ilic; Alisa Gruden-Movsesijan; Ljiljana Sofronic-Milosavljevic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

4.  The protective Th1 response in mice is induced in the T-cell zone only three weeks after infection with Leishmania major and not during early T-cell activation.

Authors:  Julia Barthelmann; Julia Nietsch; Maike Blessenohl; Tamas Laskay; Ger van Zandbergen; Jürgen Westermann; Kathrin Kalies
Journal:  Med Microbiol Immunol       Date:  2011-05-06       Impact factor: 3.402

5.  Effects of Leishmania major clones showing different levels of virulence on infectivity, differentiation and maturation of human dendritic cells.

Authors:  W Markikou-Ouni; Y Ben Achour-Chenik; A Meddeb-Garnaoui
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

6.  Cestode antigens induce a tolerogenic-like phenotype and inhibit LPS inflammatory responses in human dendritic cells.

Authors:  César A Terrazas; Fausto Sánchez-Muñoz; Ana M Mejía-Domínguez; Luis M Amezcua-Guerra; Luis I Terrazas; Rafael Bojalil; Lorena Gómez-García
Journal:  Int J Biol Sci       Date:  2011-11-01       Impact factor: 6.580

7.  Leishmania infantum and Leishmania braziliensis: Differences and Similarities to Evade the Innate Immune System.

Authors:  Sarah de Athayde Couto Falcão; Tatiana M G Jaramillo; Luciana G Ferreira; Daniela M Bernardes; Jaime M Santana; Cecília B F Favali
Journal:  Front Immunol       Date:  2016-08-03       Impact factor: 7.561

8.  Protective and pathologic immune responses in human tegumentary leishmaniasis.

Authors:  Lucas P Carvalho; Sara Passos; Albert Schriefer; Edgar M Carvalho
Journal:  Front Immunol       Date:  2012-10-04       Impact factor: 7.561

Review 9.  Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection.

Authors:  Judith Maxwell Silverman; Neil E Reiner
Journal:  Front Cell Infect Microbiol       Date:  2012-01-09       Impact factor: 5.293

10.  Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.

Authors:  Wafa Markikou-Ouni; Sima Drini; Narges Bahi-Jaber; Mehdi Chenik; Amel Meddeb-Garnaoui
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.